Recommendations for molecular testing in classical Ph1-neg myeloproliferative disorders–A consensus project of the Italian Society of Hematology

This publication has 88 references indexed in Scilit:

• Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study
  Leukemia, 2013
• JAK2 p.V617F allele burden in myeloproliferative neoplasms one month after allogeneic stem cell transplantation significantly predicts outcome and risk of relapse
  Haematologica, 2013
• Clonal evolution in UKE-1 cell line leading to an increase in JAK2 copy number
  Blood Cancer Journal, 2012
• A novel mutation in MPL (Y252H) results in increased thrombopoietin sensitivity in essential thrombocythemia
  American Journal of Hematology, 2012
• Nested High-Resolution Melting Curve Analysis
  The Journal of Molecular Diagnostics, 2011
• Hydroxyurea does not appreciably reduce JAK2 V617F allele burden in patients with polycythemia vera or essential thrombocythemia
  Haematologica, 2010
• Design and Evaluation of a Real-Time PCR Assay for Quantification of JAK2 V617F and Wild-Type JAK2 Transcript Levels in the Clinical Laboratory
  The Journal of Molecular Diagnostics, 2010
• Mutation Profile of JAK2 Transcripts in Patients with Chronic Myeloproliferative Neoplasias
  The Journal of Molecular Diagnostics, 2009
• A Sensitive Detection Method for MPLW515L or MPLW515K Mutation in Chronic Myeloproliferative Disorders with Locked Nucleic Acid-Modified Probes and Real-Time Polymerase Chain Reaction
  The Journal of Molecular Diagnostics, 2008
• JAK2Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis
  New England Journal of Medicine, 2007